October 2, 2020
A screening study is one that tests new ways to find disease early; a surveillance study investigates methods to monitor an unusual finding – such as a cyst or mole – that may or may not turn into cancer. This issue explores several such trials in breast and pancreas cancers.
October 2, 2020
This trial compares two common surveillance methods for people with at least one non-cancerous cyst in the pancreas, to measure which one leads to better outcomes. The study may also uncover findings that could predict the behavior of these cysts.
October 2, 2020
The TMIST breast cancer screening trial continues to enroll women during the COVID-19 pandemic. This article describes ways trial leaders and clinical staff are making TMIST available to women in minority communities.
October 2, 2020
Dr. Christopher Comstock, a radiologist who specializes in breast cancer imaging, talks about the results of clinical trial EA1141 and how it will hopefully give far more women access to a powerful tool in the fight against breast cancer
October 2, 2020
Cognitive loss—or ‘brain fog’—involves memory problems, a lack of mental clarity, and difficulty keeping one’s focus. Cancer-related brain fog is common during treatment. This study dispels the idea that it is only from chemotherapy.
June 10, 2020
Valerie Guild was Founder and President of the non-profit organization AIM at Melanoma, and served as a patient advocate on ECOG-ACRIN’s Melanoma Committee for over ten years.